Gene expression profiling in the prediction of response of multiple myeloma to the proteasome inhibitor PS-341.

被引：0
|
作者：
Shaughnessy, J [1 ]
Zhan, FH [1 ]
McCastlain, K [1 ]
Tian, EM [1 ]
Tricot, G [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1512
引用
收藏
页码：390A / 390A
页数：1
相关论文
共 50 条
  • [21] The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: Therapeutic applications.
    Mitsiades, N
    Mitsiades, CS
    Richardson, PG
    Poulaki, V
    Fanourakis, G
    Tai, YT
    Chauhan, D
    Schlossman, R
    Munshi, NC
    Hideshima, T
    Anderson, KC
    BLOOD, 2002, 100 (11) : 105A - 106A
  • [22] Delineation of the apoptotic cascade induced by the proteasome inhibitor PS-341 in human multiple myeloma cells using microarray profiling and functional analysis: Clinical implications.
    Mitsiades, N
    Mitsiades, CS
    Poulaki, V
    Chauhan, D
    Fanourakis, G
    Gu, XS
    Bailey, C
    Joseph, M
    Libermann, TA
    Richardson, PG
    Munshi, NC
    Hideshima, T
    Anderson, KC
    BLOOD, 2002, 100 (11) : 815A - 815A
  • [23] News about... the proteasome inhibitor PS341
    L'Allemain, G
    BULLETIN DU CANCER, 2002, 89 (01) : 29 - 30
  • [24] PS-341, a proteasome inhibitor for cancer treatment.
    Adams, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U665 - U665
  • [25] Current clinical trials for the proteasome inhibitor PS-341
    不详
    ONCOLOGY-NEW YORK, 2000, 14 (11): : 1589 - +
  • [26] Bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic apoptosis in multiple myeloma (MM) cells
    Chauhan, D
    Li, GL
    Hideshima, T
    Podar, K
    Catley, L
    Munshi, N
    Sporn, MB
    Anderson, KC
    BLOOD, 2003, 102 (11) : 935A - 935A
  • [27] Gene expression profiling and multiple myeloma
    Shaughnessy, J
    Zhan, FH
    Barlogie, B
    Stewart, AK
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (04) : 537 - 552
  • [28] Gene expression profiling of multiple myeloma
    Minvielle, S
    BULLETIN DU CANCER, 2003, 90 (02) : 127 - 130
  • [29] The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma (MM) cells.
    Hideshima, T
    Richardson, PG
    Chauhan, D
    Palombella, VJ
    Elliott, PJ
    Adams, J
    Anderson, KC
    BLOOD, 2000, 96 (11) : 461A - 461A
  • [30] The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation
    Bardag-Gorce, F
    Riley, NE
    Nan, L
    Montgomery, RO
    Li, J
    French, BA
    Lue, YH
    French, SW
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2004, 76 (01) : 9 - 16
12345